Estimated burden of serious human fungal diseases in Turkey
dc.contributor.author | Hilmioğlu-Polat S. | |
dc.contributor.author | Seyedmousavi S. | |
dc.contributor.author | Ilkit M. | |
dc.contributor.author | Hedayati M.T. | |
dc.contributor.author | Inci R. | |
dc.contributor.author | Tumbay E. | |
dc.contributor.author | Denning D.W. | |
dc.date.accessioned | 2019-10-26T21:14:06Z | |
dc.date.available | 2019-10-26T21:14:06Z | |
dc.date.issued | 2019 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | The current number of fungal infections occurring each year in Turkey is unknown. We estimated the burden of serious human fungal diseases based on the population at risk, existing epidemiological data from 1920 to 2017 and modelling previously described by the LIFE program (http://www.LIFE-worldwide.org). Among the population of Turkey (80.8 million in 2017), approximately 1 785 811 (2.21%) people are estimated to suffer from a serious fungal infection each year. The model used predicts high prevalences of allergic fungal rhinosinusitis episodes (312 994 cases) (392/100 000), of severe asthma with fungal sensitisation (42 989 cases) (53.20 cases/100 000 adults per year), of allergic bronchopulmonary aspergillosis (32 594 cases) (40.33/100 000), of fungal keratitis (26 671 cases) (33/100 000) and of chronic pulmonary aspergillosis (5890 cases) (7.29/100 000). The estimated annual incidence for invasive aspergillosis is lower (3911 cases) (4.84/100 000 annually). Among about 22.5 million women aged 15-50 years, recurrent vulvovaginal candidiasis is estimated to occur in 1 350 371 (3342/100 000) females. The burden of three superficial fungal infections was also estimated: tinea pedis (1.79 million), tinea capitis (43 900) and onychomycosis (1.73 million). Given that the modelling estimates reported in the current study might be substantially under- or overestimated, formal epidemiological and comprehensive surveillance studies are required to validate or modify these estimates. © 2018 Blackwell Verlag GmbH | en_US |
dc.description.sponsorship | National Institutes of Health National Institute of Allergy and Infectious Diseases National Institutes of Health Juvenile Diabetes Research Foundation United States of America National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health National Institute of Allergy and Infectious Diseases National Institutes of Health | en_US |
dc.description.sponsorship | 2Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States of America -- Seyedmojtaba Seyedmousavi, Molecular Microbiology Section, Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD. Email: Seyedmousavi@nih.gov -- S.S. is presently supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. All the other authors declare no conflict of interests related to this publication. -- | en_US |
dc.identifier.doi | 10.1111/myc.12842 | |
dc.identifier.endpage | 31 | en_US |
dc.identifier.issn | 0933-7407 | |
dc.identifier.issn | 0933-7407 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 22 | en_US |
dc.identifier.uri | https://doi.org/10.1111/myc.12842 | |
dc.identifier.uri | https://hdl.handle.net/11454/15836 | |
dc.identifier.volume | 62 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.relation.ispartof | Mycoses | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | candidiasis | en_US |
dc.subject | invasive aspergillosis | en_US |
dc.subject | recurrent Candida vaginitis | en_US |
dc.subject | serious fungal infection | en_US |
dc.subject | severe asthma with fungal sensitisation | en_US |
dc.subject | Turkey | en_US |
dc.title | Estimated burden of serious human fungal diseases in Turkey | en_US |
dc.type | Article | en_US |